How Much Did HealthVerity Raise? Funding & Key Investors

HealthVerity has successfully raised significant funding through multiple rounds, including a Series D round, with backing from investors such as Greycroft and Foresite Capital. The company offers a range of healthcare data solutions, including the HealthVerity Marketplace and HealthVerity FLOW.

Keep reading to explore the intricacies of HealthVerity's fundraising journey and the investors backing this innovative platform.

What Is HealthVerity?

HealthVerity, founded in 2014 by Andrew Goldberg and Andrew Kress, is headquartered in Philadelphia, Pennsylvania. The company operates within the healthcare, information services, and information technology industries.

Specializing in healthcare data solutions, HealthVerity powers the discovery, licensing, and linkage of traditional and emerging healthcare data. With an employee count ranging from 101 to 250, the company provides technologies that enable healthcare providers to integrate patient data from diverse sources, ensuring privacy and interoperability.

How Much Funding Has HealthVerity Raised?

1. Series A
   • Amount Raised: $7.2M
   • Date: April 2016
   • Lead Investors: Flare Capital Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To establish a strong foundation for the company's data solutions platform.
2. Series B
   • Amount Raised: $10M
   • Date: April 2017
   • Lead Investors: Flare Capital Partners, Greycroft
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To expand the company's data integration capabilities and enhance its technology infrastructure.
3. Series C
   • Amount Raised: $25M
   • Date: April 2019
   • Lead Investors: Foresite Capital
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To scale operations and accelerate market penetration.
4. Series D
   • Amount Raised: $100M
   • Date: June 2021
   • Lead Investors: Durable Capital Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To accelerate go-to-market initiatives, expand the real-world data ecosystem, and enhance patient identity resolution technology.

Total Amount Raised: $142.2M. Current Valuation: Not publicly disclosed.

Key Investors

• Durable Capital Partners
  • Details: Durable Capital Partners led the Series D funding round for HealthVerity. They focus on long-term investments in both public and private companies.
  • Investment Focus Areas: Public companies, private companies, growth-stage companies.
  • Notable Investments: Known for investments in companies with strong growth potential.
• Flare Capital Partners
  • Details: Flare Capital Partners is an existing investor in HealthVerity, participating in multiple funding rounds. They specialize in healthcare technology and services.
  • Investment Focus Areas: Healthcare technology, healthcare services, digital health.
  • Notable Investments: Iora Health, Health Catalyst, Bright Health.
• Foresite Capital
  • Details: Foresite Capital has been involved in HealthVerity's funding rounds, including the Series C and D rounds. They invest in healthcare and life sciences companies.
  • Investment Focus Areas: Healthcare, life sciences, biotechnology.
  • Notable Investments: 10X Genomics, Denali Therapeutics, Relay Therapeutics.
• Greycroft
  • Details: Greycroft is an existing investor in HealthVerity, participating in the Series B and D rounds. They invest in internet and mobile companies across various stages.
  • Investment Focus Areas: Internet, mobile, technology.
  • Notable Investments: Venmo, The RealReal, Scopely.

What's Next for HealthVerity?

HealthVerity stands at the cusp of significant growth opportunities. With the recent $100 million Series D funding, the company is poised to accelerate its go-to-market initiatives and expand its real-world data ecosystem. This financial backing underscores the vast potential for leveraging healthcare data to solve complex industry challenges.

Future fundraising opportunities seem promising, given the strong support from prominent investors. As HealthVerity continues to enhance its patient identity resolution technology, it may attract further investments to scale its operations and broaden its market reach.

However, the path forward is not without challenges. The company must navigate competition from other healthcare data solution providers and ensure compliance with stringent data privacy regulations. Successfully addressing these hurdles will be crucial for sustaining its growth trajectory.

Use Clay to Get Funding Data

Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like HealthVerity and gather other critical business insights.

Sign up for free to start exploring the wealth of information available at your fingertips.